Drugs Made In America Acquisition II Rights Exp 16 Sep 2030
DMIIR
View Detailed Chart
0.140USD
-0.010-6.47%
Close 12/10, 16:00（ET）Quotes delayed by 15 min
--Market Cap
--P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-6.47%
5 Days
0.00%
1 Month
0.00%
6 Months
0.00%
Year to Date
0.00%
1 Year
0.00%
View Detailed Chart
TradingKey Stock Score
No stock score available due to insufficient data.
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 Info
Drugs Made In America Acquisition II Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to search for business combination targets in the pharmaceutical industry. The Company is neither engaged in any operations nor generated any revenues.
Ticker SymbolDMIIR
CompanyDrugs Made In America Acquisition II Rights Exp 16 Sep 2030
CEOStockwell (Lynn)
Website
FAQs
What is the current price of Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 (DMIIR)?
The current price of Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 (DMIIR) is 0.140.
What is the symbol of Drugs Made In America Acquisition II Rights Exp 16 Sep 2030?
The ticker symbol of Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 is DMIIR.
What is the 52-week high of Drugs Made In America Acquisition II Rights Exp 16 Sep 2030?
The 52-week high of Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 is 0.170.
What is the 52-week low of Drugs Made In America Acquisition II Rights Exp 16 Sep 2030?
The 52-week low of Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 is 0.140.
What is the market capitalization of Drugs Made In America Acquisition II Rights Exp 16 Sep 2030?
The market capitalization of Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 is --.
What is the net income of Drugs Made In America Acquisition II Rights Exp 16 Sep 2030?
The net income of Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 is --.
Is Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 (DMIIR) currently rated as Buy, Hold, or Sell?
According to analysts, Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 (DMIIR) has an overall rating of --, with a price target of --.
What is the Earnings Per Share (EPS TTM) of Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 (DMIIR)?
The Earnings Per Share (EPS TTM) of Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 (DMIIR) is --.
